Clinical phenotype of severe and moderate haemophilia: Who should receive prophylaxis and what is the target trough level?

Collins, Peter W; Obaji, Samya G; Roberts, Heledd; Gorsani, Deepan; Rayment, Rachel

Collins, Peter W; Obaji, Samya G; Roberts, Heledd; Gorsani, Deepan; Rayment, Rachel.

Afiliação

Collins PW; Cardiff Haemophilia Centre, Cardiff and Vale University Health Board, Cardiff, UK.
Obaji SG; Institute of Infection and Immunity, School of Medicine Cardiff University, Cardiff, UK.
Roberts H; Cardiff Haemophilia Centre, Cardiff and Vale University Health Board, Cardiff, UK.
Gorsani D; Institute of Infection and Immunity, School of Medicine Cardiff University, Cardiff, UK.
Rayment R; Cardiff Haemophilia Centre, Cardiff and Vale University Health Board, Cardiff, UK.

Haemophilia ; 27(2): 192-198, 2021 Mar.

Article em En | MEDLINE | ID: mdl-33639027

Assuntos

Hemofilia A; Fator VIII; Hemartrose; Hemofilia A/tratamento farmacológico; Hemorragia/prevenção & controle; Humanos; Fenótipo

Palavras-chave

arthropathy; haemophilia; moderate; prophylaxis; trough level

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hemofilia A Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Haemophilia Assunto da revista: HEMATOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google